Effect of Combination Therapy on Metabolic Outcomes Based on a 2019 meta-analysis of seven randomised controlled trials (1,913 participants) with a primary duration ranging from 12 to 30 weeks, co-administration of SGLT-2 inhibitors and GLP-1 receptor agonists had a less than additive effect on HbA 1c and body weight and an additive reduction in systolic blood pressure compared with each monocomponent without increasing risk of hypoglycaemia [5]
Ajabnoor GMA, Hashim KT, Alzahrani MM, Alsuheili AZ, Alharbi AF, Alhozali AM, Enani S, Eldakhakhny B, Elsamanoudy A
What does clinical evidence say about long-term weight maintenance after GLP-1 therapy stops
To sum up, current data suggests that semaglutide does not significantly increase the risk of complications during a colonoscopy
Its Me Hanis
Download MeAgain today and start tracking your results: safely, effectively, and with a bit of fun along the way.